TY - JOUR
T1 - Impact of reproductive factors on breast cancer incidence
T2 - Pooled analysis of nine cohort studies in Japan
AU - for the Research Group for the Development, Evaluation of Cancer Prevention Strategies in Japan
AU - Takeuchi, Taro
AU - Kitamura, Yuri
AU - Sobue, Tomotaka
AU - Utada, Mai
AU - Ozasa, Kotaro
AU - Sugawara, Yumi
AU - Tsuji, Ichiro
AU - Hori, Miyuki
AU - Sawada, Norie
AU - Tsugane, Shoichiro
AU - Koyanagi, Yuriko N.
AU - Ito, Hidemi
AU - Wang, Chaochen
AU - Tamakoshi, Akiko
AU - Wada, Keiko
AU - Nagata, Chisato
AU - Shimazu, Taichi
AU - Mizoue, Tetsuya
AU - Matsuo, Keitaro
AU - Naito, Mariko
AU - Tanaka, Keitaro
AU - Inoue, Manami
N1 - Funding Information:
Taro Takeuchi was supported by the Osaka University Medical Doctor Scientist Training Program. The Radiation Effects Research Foundation (RERF) is funded by Japan and The US government (RERF Research Protocol A2‐15). This study was supported by the National Cancer Center Research and Development Fund (30‐A‐15, 27‐A‐4, 24‐A‐3) and the Health and Labour Sciences Research Grants for the Third Term Comprehensive Control Research for Cancer (H21‐3jigan‐ippan‐003, H18‐3jigan‐ippan‐001, H16‐3jigan‐010)
Publisher Copyright:
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
PY - 2021/3
Y1 - 2021/3
N2 - Prior studies reported the association of reproductive factors with breast cancer (BC), but the evidence is inconsistent. We conducted a pooled analysis of nine cohort studies in Japan to evaluate the impact of six reproductive factors (age at menarche/age at first birth/number of births/age at menopause/use of female hormones/breastfeeding) on BC incidence. We conducted analyses according to menopausal status at the baseline or at the diagnosis. Hazard ratio (HR) and 95% confidence interval (CI) were estimated by applying Cox proportional-hazards model in each study. These hazard ratios were integrated using a random-effects model. Among 187,999 women (premenopausal: 61,113, postmenopausal: 126,886), we observed 873 premenopausal and 1,456 postmenopausal cases. Among premenopausal women, use of female hormones significantly increased BC incidence (HR: 1.53 [1.04–2.25]). Although P value for trend was not significant for age at first birth and number of births (P for trend: 0.15 and 0.30, respectively), women giving first birth at ages ≥36 experienced significantly higher BC incidence than at ages 21–25 years, and women who had ≥2 births experienced significantly lower BC incidence than nulliparous women. Among postmenopausal women, more births significantly decreased BC incidence (P for trend: 0.03). Although P value for trend was not significant for age at first birth and age at menopause (P for trend: 0.30 and 0.37, respectively), women giving first birth at ages 26–35 years experienced significantly higher BC incidence than at ages 21–25 years, and women with age at menopause: ≥50 years experienced significantly higher BC incidence than age at menopause: ≤44 years. BC incidence was similar according to age at menarche or breastfeeding history among both premenopausal and postmenopausal women. In conclusion, among Japanese women, use of female hormones increased BC incidence in premenopausal women, and more births decreased BC incidence in postmenopausal women.
AB - Prior studies reported the association of reproductive factors with breast cancer (BC), but the evidence is inconsistent. We conducted a pooled analysis of nine cohort studies in Japan to evaluate the impact of six reproductive factors (age at menarche/age at first birth/number of births/age at menopause/use of female hormones/breastfeeding) on BC incidence. We conducted analyses according to menopausal status at the baseline or at the diagnosis. Hazard ratio (HR) and 95% confidence interval (CI) were estimated by applying Cox proportional-hazards model in each study. These hazard ratios were integrated using a random-effects model. Among 187,999 women (premenopausal: 61,113, postmenopausal: 126,886), we observed 873 premenopausal and 1,456 postmenopausal cases. Among premenopausal women, use of female hormones significantly increased BC incidence (HR: 1.53 [1.04–2.25]). Although P value for trend was not significant for age at first birth and number of births (P for trend: 0.15 and 0.30, respectively), women giving first birth at ages ≥36 experienced significantly higher BC incidence than at ages 21–25 years, and women who had ≥2 births experienced significantly lower BC incidence than nulliparous women. Among postmenopausal women, more births significantly decreased BC incidence (P for trend: 0.03). Although P value for trend was not significant for age at first birth and age at menopause (P for trend: 0.30 and 0.37, respectively), women giving first birth at ages 26–35 years experienced significantly higher BC incidence than at ages 21–25 years, and women with age at menopause: ≥50 years experienced significantly higher BC incidence than age at menopause: ≤44 years. BC incidence was similar according to age at menarche or breastfeeding history among both premenopausal and postmenopausal women. In conclusion, among Japanese women, use of female hormones increased BC incidence in premenopausal women, and more births decreased BC incidence in postmenopausal women.
KW - breast cancer
KW - cancer risk factors
KW - epidemiology and prevention
KW - meta-analysis
UR - http://www.scopus.com/inward/record.url?scp=85102458249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102458249&partnerID=8YFLogxK
U2 - 10.1002/cam4.3752
DO - 10.1002/cam4.3752
M3 - Article
AN - SCOPUS:85102458249
SN - 2045-7634
VL - 10
SP - 2153
EP - 2163
JO - Cancer Medicine
JF - Cancer Medicine
IS - 6
ER -